{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:56:07Z","timestamp":1768413367388,"version":"3.49.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000692","name":"Royal College of Surgeons of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.suronc.2019.07.007","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T11:34:59Z","timestamp":1564745699000},"page":"147-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Hepatic steatosis in patients undergoing resection of colorectal liver metastases: A target for prehabilitation? A narrative review"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8532-3420","authenticated-orcid":false,"given":"D.T.","family":"Doherty","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.O.","family":"Coe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Rimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lapsia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Krige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.A.","family":"Subar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.suronc.2019.07.007_bib1","first-page":"283","article-title":"Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors","volume":"4","author":"Kanas","year":"2012","journal-title":"Clin Epidemiol"},{"issue":"April","key":"10.1016\/j.suronc.2019.07.007_bib2","article-title":"Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases","volume":"20","author":"Correa-Gallego","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.suronc.2019.07.007_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/j.1477-2574.2012.00596.x","article-title":"Early post\u2010operative prediction of morbidity and mortality after a major liver resection for colorectal metastases","volume":"15","author":"Gr\u0105t","year":"2013","journal-title":"HPB"},{"issue":"5","key":"10.1016\/j.suronc.2019.07.007_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.9060","article-title":"Impact of complications on long-term survival after resection of colorectal liver metastases","volume":"100","author":"Mavros","year":"2013","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.suronc.2019.07.007_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/hpb.12007","article-title":"The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy","volume":"15","author":"Parkin","year":"2013","journal-title":"HPB"},{"issue":"11","key":"10.1016\/j.suronc.2019.07.007_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2014.07.040","article-title":"Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy","volume":"40","author":"Parkin","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"10.1016\/j.suronc.2019.07.007_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.gassur.2003.09.012","article-title":"Impact of steatosis on perioperative outcome following hepatic resection","volume":"7","author":"Kooby","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.suronc.2019.07.007_bib8","doi-asserted-by":"crossref","unstructured":"Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg [Internet]. 2(3):292\u20138. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9841987[cited 2016 Dec 2].","DOI":"10.1016\/S1091-255X(98)80025-5"},{"issue":"9","key":"10.1016\/j.suronc.2019.07.007_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.7194","article-title":"Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection","volume":"97","author":"de Meijer","year":"2010","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/gutjnl-2011-300155","article-title":"MRI: the new reference standard in quantifying hepatic steatosis?","volume":"61","author":"Raptis","year":"2012","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.suronc.2019.07.007_bib11","doi-asserted-by":"crossref","DOI":"10.3945\/ajcn.110.007674","article-title":"Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction","volume":"93","author":"Browning","year":"2011","journal-title":"Am J Clin Nutr"},{"issue":"945","key":"10.1016\/j.suronc.2019.07.007_bib12","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1259\/bjr\/23166141","article-title":"Low-carbohydrate diet induced reduction of hepatic lipid content observed with a rapid non-invasive MRI technique","volume":"79","author":"Hollingsworth","year":"2006","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1016\/j.suronc.2019.07.007_bib13","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2004-1983","article-title":"Dietary fat content modifies liver fat in overweight nondiabetic subjects","volume":"90","author":"Westerbacka","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib14","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","article-title":"The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease","volume":"59","author":"Ryan","year":"2013","journal-title":"J. Hepatol."},{"issue":"06","key":"10.1016\/j.suronc.2019.07.007_bib15","doi-asserted-by":"crossref","DOI":"10.1017\/S0007114512002966","article-title":"Beneficial effect of a weight-stable, low-fat\/low-saturated fat\/low-glycaemic index diet to reduce liver fat in older subjects","volume":"109","author":"Utzschneider","year":"2013","journal-title":"Br J Nutr"},{"issue":"11","key":"10.1016\/j.suronc.2019.07.007_bib16","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.3390\/nu6114678","article-title":"Effects of dietary fat and saturated fat content on liver fat and markers of oxidative stress in overweight\/obese men and women under weight-stable conditions","volume":"6","author":"Marina","year":"2014","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.suronc.2019.07.007_bib17","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cld.81","article-title":"Nonalcoholic fatty liver disease: definitions, risk factors, and workup","volume":"1","author":"Puri","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"6","key":"10.1016\/j.suronc.2019.07.007_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MCG.0000000000000116","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"48","author":"LaBrecque","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.suronc.2019.07.007_bib19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1365-2796.2011.02377.x","article-title":"Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia","volume":"270","author":"Stadlmayr","year":"2011","journal-title":"J. Intern. Med."},{"issue":"5","key":"10.1016\/j.suronc.2019.07.007_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/hep.21827","article-title":"Incidence and natural course of fatty liver in the general population: the Dionysos study","volume":"46","author":"Bedogni","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.suronc.2019.07.007_bib21","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.numecd.2005.08.006","article-title":"Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk","volume":"16","author":"Panagiotakos","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.suronc.2019.07.007_bib22","first-page":"341","article-title":"Origins and evolution of the Western diet\u202f: health implications for the 21st century","volume":"81","author":"Cordain","year":"2005","journal-title":"Am J Cl"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1158\/1055-9965.138.14.1","article-title":"Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women","volume":"14","author":"Michaud","year":"2005","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.suronc.2019.07.007_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2018.01.015","article-title":"High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance","author":"Zelber-Sagi","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ijc.24343","article-title":"The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence","volume":"125","author":"Huxley","year":"2009","journal-title":"Int J Cancer"},{"issue":"13","key":"10.1016\/j.suronc.2019.07.007_bib26","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"issue":"9617","key":"10.1016\/j.suronc.2019.07.007_bib27","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.suronc.2019.07.007_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.suronc.2019.07.007_bib29","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ejca.2007.07.017","article-title":"Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group","volume":"43","author":"Nordlinger","year":"2007","journal-title":"Eur. J. Cancer"},{"issue":"9617","key":"10.1016\/j.suronc.2019.07.007_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(09)70330-4","article-title":"Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial","volume":"11","author":"Folprecht","year":"2010","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2019.07.007_bib32","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.948.65.3","article-title":"Controlling tumor growth by modulating endogenous production of reactive oxygen species","volume":"65","author":"Laurent","year":"2005","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.suronc.2019.07.007_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djj049","article-title":"Improvement of the therapeutic index of anticancer drugs by the superoxide dismutase mimic mangafodipir","volume":"98","author":"Alexandre","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2012.08.030","article-title":"Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience","volume":"216","author":"Wolf","year":"2013","journal-title":"J Am Coll Surg"},{"issue":"6","key":"10.1016\/j.suronc.2019.07.007_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2005.01.024","article-title":"Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases","volume":"200","author":"Fernandez","year":"2005","journal-title":"J Am Coll Surg"},{"issue":"31","key":"10.1016\/j.suronc.2019.07.007_bib36","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.suronc.2019.07.007_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.gassur.2003.08.005","article-title":"Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy","volume":"7","author":"Parikh","year":"2003","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib38","doi-asserted-by":"crossref","DOI":"10.4132\/KoreanJPathol.2012.46.1.22","article-title":"Chemotherapy-associated hepatopathy in Korean colorectal cancer liver metastasis patients: oxaliplatin-based chemotherapy and sinusoidal injury","volume":"46","author":"Nam","year":"2012","journal-title":"Korean J Pathol"},{"issue":"7","key":"10.1016\/j.suronc.2019.07.007_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjc.6603670","article-title":"Safe liver resection following chemotherapy for colorectal metastases is a matter of timing","volume":"96","author":"Welsh","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.suronc.2019.07.007_bib40","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1634\/theoncologist.2009-0071","article-title":"Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study axel GROTHEY g for the investigators OF the brite study","volume":"14","author":"Kozloff","year":"2009","journal-title":"The Oncologist"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00423-015-1352-5","article-title":"Effects of oxaliplatin-based chemotherapy on liver function\u2014an analysis of impact and functional recovery using the LiMAx test","volume":"401","author":"Jara","year":"2016","journal-title":"Langenbeck's Arch. Surg."},{"issue":"11","key":"10.1016\/j.suronc.2019.07.007_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.5820","article-title":"Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis","volume":"94","author":"Gomez","year":"2007","journal-title":"Br J Surg"},{"issue":"6","key":"10.1016\/j.suronc.2019.07.007_bib43","doi-asserted-by":"crossref","DOI":"10.1097\/01.sla.0000251747.80025.b7","article-title":"Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy","volume":"245","author":"McCormack","year":"2007","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.suronc.2019.07.007_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.hpb.2017.11.007","article-title":"Prospective evaluation of the International Study Group for Liver Surgery definition of post hepatectomy liver failure after liver resection: an international multicentre study","volume":"20","author":"Sultana","year":"2018","journal-title":"HPB"},{"issue":"4","key":"10.1016\/j.suronc.2019.07.007_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.hpb.2015.12.002","article-title":"The influence of steatosis on the short- and long-term results of resection of liver metastases from colorectal carcinoma","volume":"18","author":"Ramos","year":"2016","journal-title":"HPB"},{"issue":"4","key":"10.1016\/j.suronc.2019.07.007_bib46","doi-asserted-by":"crossref","DOI":"10.3892\/mco.2017.1358","article-title":"Blood transfusions and steatohepatitis are independent risk factors for complications following liver resection for colorectal cancer liver metastases","volume":"7","author":"Massani","year":"2017","journal-title":"Mol Clin Oncol"},{"issue":"8","key":"10.1016\/j.suronc.2019.07.007_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.10572","article-title":"Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases","volume":"104","author":"Zhao","year":"2017","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.suronc.2019.07.007_bib48","doi-asserted-by":"crossref","DOI":"10.1111\/j.1477-2574.2012.00454.x","article-title":"Correlations between histopathological diagnosis of chemotherapy-induced hepatic injury, clinical features, and perioperative morbidity","volume":"14","author":"Pilgrim","year":"2012","journal-title":"HPB"},{"issue":"2","key":"10.1016\/j.suronc.2019.07.007_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2012.05.037","article-title":"Effect of metabolic syndrome on perioperative outcomes after liver surgery: a National Surgical Quality Improvement Program (NSQIP) analysis","volume":"152","author":"Bhayani","year":"2012","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.8963","article-title":"Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome","volume":"100","author":"Cauchy","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.suronc.2019.07.007_bib51","doi-asserted-by":"crossref","DOI":"10.1007\/s00268-019-04996-y","article-title":"Short- and long-term outcomes of liver resection for intrahepatic cholangiocarcinoma associated with the metabolic syndrome","author":"Hobeika","year":"2019","journal-title":"World J Surg"},{"issue":"6","key":"10.1016\/j.suronc.2019.07.007_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.suronc.2019.07.007_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/hep.25889","article-title":"Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients","volume":"56","author":"Bedossa","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.suronc.2019.07.007_bib54","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0b013e3181bcd6dd","article-title":"Assessment of hepatic steatosis by expert pathologists","volume":"250","author":"El-Badry","year":"2009","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.suronc.2019.07.007_bib55","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-010-1254-x","article-title":"Digital quantification is more precise than traditional semiquantitation of hepatic steatosis: correlation with fibrosis in 220 treatment-na\u00efve patients with chronic hepatitis C","volume":"55","author":"Rawlins","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/jmri.21201","article-title":"Comparison of fat quantification methods: a phantom study at 3.0T","volume":"27","author":"Bernard","year":"2008","journal-title":"J Magn Reson Imaging"},{"issue":"8","key":"10.1016\/j.suronc.2019.07.007_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2015.05.001","article-title":"Liver fat quantification: comparison of dual-echo and triple-echo chemical shift MRI to MR spectroscopy","volume":"84","author":"Satkunasingham","year":"2015","journal-title":"Eur J Radiol"},{"issue":"8","key":"10.1016\/j.suronc.2019.07.007_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2015.05.003","article-title":"Digital histology quantification of intra-hepatic fat in patients undergoing liver resection","volume":"41","author":"Parkin","year":"2015","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.suronc.2019.07.007_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2017.11.013","article-title":"Non-invasive assessment of non-alcoholic fatty liver disease: clinical prediction rules and blood-based biomarkers","volume":"68","author":"Vilar-Gomez","year":"2018","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.suronc.2019.07.007_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/j.1478-3231.2005.01209.x","article-title":"Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease","volume":"26","author":"Palekar","year":"2006","journal-title":"Liver Int"},{"issue":"6","key":"10.1016\/j.suronc.2019.07.007_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/hep.22241","article-title":"A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients","volume":"47","author":"Campos","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.suronc.2019.07.007_bib62","doi-asserted-by":"crossref","DOI":"10.1002\/hep.23050","article-title":"Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study","volume":"50","author":"Feldstein","year":"2009","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.suronc.2019.07.007_bib63","doi-asserted-by":"crossref","DOI":"10.1007\/s11695-008-9506-y","article-title":"A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)","volume":"18","author":"Younossi","year":"2008","journal-title":"Obes Surg"},{"key":"10.1016\/j.suronc.2019.07.007_bib64","series-title":"PLoS One","article-title":"Cytokeratin 18, alanine aminotransferase, platelets and triglycerides predict the presence of nonalcoholic steatohepatitis","volume":"8","author":"Cao","year":"2013"},{"key":"10.1016\/j.suronc.2019.07.007_bib65","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-019-06076-0","article-title":"Prediction of nonalcoholic fatty liver disease (NAFLD) activity score (NAS) with multiparametric hepatic magnetic resonance imaging and elastography","author":"Yin","year":"2019","journal-title":"Eur Radiol"},{"issue":"13","key":"10.1016\/j.suronc.2019.07.007_bib66","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.suronc.2019.07.007_bib67","series-title":"PLoS One","article-title":"Perioperative non-invasive indocyanine green-clearance testing to predict postoperative outcome after liver resection","volume":"11","author":"Haegele","year":"2016"},{"issue":"9","key":"10.1016\/j.suronc.2019.07.007_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2009.02.003","article-title":"Perioperative use of the LiMON method of indocyanine green elimination measurement for the prediction and early detection of post-hepatectomy liver failure","volume":"35","author":"de Liguori Carino","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"10.1016\/j.suronc.2019.07.007_bib69","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1477-2574.2011.00365.x","article-title":"MRNA gene expression correlates with histologically diagnosed chemotherapy-induced hepatic injury","volume":"13","author":"Pilgrim","year":"2011","journal-title":"HPB"},{"issue":"3","key":"10.1016\/j.suronc.2019.07.007_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2018.01.005","article-title":"An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans","volume":"27","author":"Mardinoglu","year":"2018","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/j.suronc.2019.07.007_bib71","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.10.007","article-title":"Isocaloric diets high in animal or plant protein reduce liver fat and inflammation in individuals with type 2 diabetes","volume":"152","author":"Markova","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.suronc.2019.07.007_bib72","doi-asserted-by":"crossref","DOI":"10.1007\/s11695-010-0337-2","article-title":"Preoperative 4-week low-calorie diet reduces liver volume and intrahepatic fat, and facilitates laparoscopic gastric bypass in morbidly obese","volume":"21","author":"Edholm","year":"2011","journal-title":"Obes Surg"},{"issue":"2","key":"10.1016\/j.suronc.2019.07.007_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/ajcn\/84.2.304","article-title":"Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging","volume":"84","author":"Colles","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"10.1016\/j.suronc.2019.07.007_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2013.04.012","article-title":"Short-term preoperative diet modification reduces steatosis and blood loss in patients undergoing liver resection","volume":"154","author":"Reeves","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.suronc.2019.07.007_bib75","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2009.01.048","article-title":"Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction","author":"Kirk","year":"2009","journal-title":"Gastroenterology"},{"issue":"10019","key":"10.1016\/j.suronc.2019.07.007_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.suronc.2019.07.007_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/oby.2011.152","article-title":"Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes","volume":"19","author":"Sathyanarayana","year":"2011","journal-title":"Obesity"},{"issue":"10","key":"10.1016\/j.suronc.2019.07.007_bib78","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2009-0870","article-title":"Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy","volume":"94","author":"Cussons","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.suronc.2019.07.007_bib79","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-010-1074-4","article-title":"Recovery of liver function after the cessation of preoperative chemotherapy for colorectal liver metastasis","volume":"17","author":"Takamoto","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.suronc.2019.07.007_bib80","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13104-015-1055-6","article-title":"Noninvasive diagnosis of chemotherapy induced liver injury by LiMAx test--two case reports and a review of the literature","volume":"8","author":"Bednarsch","year":"2015","journal-title":"BMC Res Notes"},{"issue":"9","key":"10.1016\/j.suronc.2019.07.007_bib81","doi-asserted-by":"crossref","DOI":"10.1245\/s10434-017-5887-2","article-title":"LiMAx test improves diagnosis of chemotherapy-associated liver injury before resection of colorectal liver metastases","volume":"24","author":"Lock","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.suronc.2019.07.007_bib82","doi-asserted-by":"crossref","DOI":"10.1097\/RCT.0b013e3181cd3304","article-title":"Relationship between liver function and liver signal intensity in hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging","volume":"34","author":"Tajima","year":"2010","journal-title":"J Comput Assist Tomogr"},{"issue":"5","key":"10.1016\/j.suronc.2019.07.007_bib83","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-014-3108-y","article-title":"Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla","volume":"24","author":"Verloh","year":"2014","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.suronc.2019.07.007_bib84","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/01.rli.0000258058.44876.a5","article-title":"Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging","volume":"42","author":"Tsuda","year":"2007","journal-title":"Invest Radiol"},{"issue":"4","key":"10.1016\/j.suronc.2019.07.007_bib85","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-011-2446-4","article-title":"Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials","volume":"55","author":"Musso","year":"2012","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/S1091-255X(01)00019-1","article-title":"Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer","volume":"6","author":"Little","year":"2002","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.suronc.2019.07.007_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2009.09.004","article-title":"Hepatic steatosis, body mass index and long term outcome in patients undergoing hepatectomy for colorectal liver metastases","author":"Pathak","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.suronc.2019.07.007_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.9057","article-title":"Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases","volume":"100","author":"Hamady","year":"2013","journal-title":"Br J Surg"},{"issue":"5","key":"10.1016\/j.suronc.2019.07.007_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/nrgastro.2013.53","article-title":"Metastatic colorectal cancer outcome and fatty liver disease","volume":"10","author":"Brouquet","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib90","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.54","article-title":"Metformin use and improved response to therapy in rectal cancer","volume":"2","author":"Skinner","year":"2013","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.suronc.2019.07.007_bib91","doi-asserted-by":"crossref","DOI":"10.2337\/dc09-1380","article-title":"Metformin associated with lower cancer mortality in type 2 diabetes","volume":"33","author":"Landman","year":"2010","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.suronc.2019.07.007_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/bjc.2012.71","article-title":"Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer","volume":"106","author":"Garrett","year":"2012","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.suronc.2019.07.007_bib93","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-11-2994","article-title":"Metformin use is associated with better survival of diabetic patients with pancreatic cancer","volume":"18","author":"Sadeghi","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.suronc.2019.07.007_bib94","doi-asserted-by":"crossref","DOI":"10.2337\/dc09-1791","article-title":"Long-term metformin use is associated with decreased risk of breast cancer","volume":"33","author":"Bodmer","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.suronc.2019.07.007_bib95","author":"ClinicalTrialsgov"},{"issue":"7","key":"10.1016\/j.suronc.2019.07.007_bib96","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.28809","article-title":"Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancer","volume":"135","author":"Poff","year":"2014","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.suronc.2019.07.007_bib97","doi-asserted-by":"crossref","DOI":"10.1186\/1743-7075-5-33","article-title":"Drug\/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet","volume":"5","author":"Marsh","year":"2008","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.suronc.2019.07.007_bib98","series-title":"PLoS One","article-title":"The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma","volume":"7","author":"Abdelwahab","year":"2012"},{"issue":"10","key":"10.1016\/j.suronc.2019.07.007_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2012.05.001","article-title":"Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients","volume":"28","author":"Fine","year":"2012","journal-title":"Nutrition"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740418303797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740418303797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T03:18:09Z","timestamp":1760757489000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740418303797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":99,"alternative-id":["S0960740418303797"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2019.07.007","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic steatosis in patients undergoing resection of colorectal liver metastases: A target for prehabilitation? A narrative review","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2019.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}